Statin-Induced Immune-Mediated Necrotizing Myopathy with Anti-HMGCR Antibody / 대한신경근육질환학회지
Korean Journal of Neuromuscular Disorders
; (2): 64-66, 2021.
Article
em Ko
| WPRIM
| ID: wpr-917945
Biblioteca responsável:
WPRO
ABSTRACT
Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (anti-HMGCR) antibody related immune-mediated necrotizing myopathy (IMNM) are usually associated with statin use. The disease has features of persistent muscle weakness and creatine kinase (CK) elevation after statin discontinuation. This report describes a 65-year-old female taking atorvastatin, presenting with both proximal lower extremity weakness. IMNM feature were detected on muscle biopsy and high anti-HMGCR autoantibody titer on enzyme-linked immunosorbent assay (ELISA). This patient was treated with corticosteroid. Muscle weakness and CK are improved after immunosuppressive therapy.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Ko
Revista:
Korean Journal of Neuromuscular Disorders
Ano de publicação:
2021
Tipo de documento:
Article